BACKGROUND: Four genes responsible for pseudohypoaldosteronism type II (PHA-II) have been identified, thereby facilitating molecular diagnostic testing. CASE-DIAGNOSIS/TREATMENT: A 1-year-old boy with prolonged hyperkalemia, metabolic acidosis, hyperchloremia, growth delay, and mild hypertension was diagnosed with PHA-II based on the detection of exon 9 skipping in CUL3 mRNA. The impaired splicing was the result of a de novo, previously unreported single nucleotide substitution in the splice acceptor site of CUL3 intron 8. Among the four genes reported to be involved in PHA-II, CUL3 was the primary suspect in our patient because in patients with the CUL3 mutation, the onset of disease is often early in infancy and the phenotypes of PHA-II are more severe. Our patient was treated with trichlormethiazide, which inhibits the function of the sodium-chloride co-transporter (NCC), and the outcome was favorable, with correction of body fluids and blood electrolyte homeostasis. CONCLUSION: Since chronic acidosis and hypertension associated with PHA-II can result in delayed growth and development in pediatric patients, genetic analysis to detect the CUL3 mutation and to enable intervention early in the disease course would be beneficial for infants with suspected PHA-II.
BACKGROUND: Four genes responsible for pseudohypoaldosteronism type II (PHA-II) have been identified, thereby facilitating molecular diagnostic testing. CASE-DIAGNOSIS/TREATMENT: A 1-year-old boy with prolonged hyperkalemia, metabolic acidosis, hyperchloremia, growth delay, and mild hypertension was diagnosed with PHA-II based on the detection of exon 9 skipping in CUL3 mRNA. The impaired splicing was the result of a de novo, previously unreported single nucleotide substitution in the splice acceptor site of CUL3 intron 8. Among the four genes reported to be involved in PHA-II, CUL3 was the primary suspect in our patient because in patients with the CUL3 mutation, the onset of disease is often early in infancy and the phenotypes of PHA-II are more severe. Our patient was treated with trichlormethiazide, which inhibits the function of the sodium-chloride co-transporter (NCC), and the outcome was favorable, with correction of body fluids and blood electrolyte homeostasis. CONCLUSION: Since chronic acidosis and hypertension associated with PHA-II can result in delayed growth and development in pediatric patients, genetic analysis to detect the CUL3 mutation and to enable intervention early in the disease course would be beneficial for infants with suspected PHA-II.
Authors: F H Wilson; S Disse-Nicodème; K A Choate; K Ishikawa; C Nelson-Williams; I Desitter; M Gunel; D V Milford; G W Lipkin; J M Achard; M P Feely; B Dussol; Y Berland; R J Unwin; H Mayan; D B Simon; Z Farfel; X Jeunemaitre; R P Lifton Journal: Science Date: 2001-08-10 Impact factor: 47.728
Authors: Lynn M Boyden; Murim Choi; Keith A Choate; Carol J Nelson-Williams; Anita Farhi; Hakan R Toka; Irina R Tikhonova; Robert Bjornson; Shrikant M Mane; Giacomo Colussi; Marcel Lebel; Richard D Gordon; Ben A Semmekrot; Alain Poujol; Matti J Välimäki; Maria E De Ferrari; Sami A Sanjad; Michael Gutkin; Fiona E Karet; Joseph R Tucci; Jim R Stockigt; Kim M Keppler-Noreuil; Craig C Porter; Sudhir K Anand; Margo L Whiteford; Ira D Davis; Stephanie B Dewar; Alberto Bettinelli; Jeffrey J Fadrowski; Craig W Belsha; Tracy E Hunley; Raoul D Nelson; Howard Trachtman; Trevor R P Cole; Maury Pinsk; Detlef Bockenhauer; Mohan Shenoy; Priya Vaidyanathan; John W Foreman; Majid Rasoulpour; Farook Thameem; Hania Z Al-Shahrouri; Jai Radhakrishnan; Ali G Gharavi; Beatrice Goilav; Richard P Lifton Journal: Nature Date: 2012-01-22 Impact factor: 49.962
Authors: Chong Zhang; Nicholas P Meermeier; Andrew S Terker; Katharina I Blankenstein; Jeffrey D Singer; Juliette Hadchouel; David H Ellison; Chao-Ling Yang Journal: Biochem Biophys Res Commun Date: 2015-11-23 Impact factor: 3.575
Authors: Harish E Chatrathi; Jason C Collins; Lynne A Wolfe; Thomas C Markello; David R Adams; William A Gahl; Achim Werner; Prashant Sharma Journal: Hypertension Date: 2021-12-02 Impact factor: 10.190
Authors: Luz G Cervantes-Perez; Maria Castaneda-Bueno; Jose V Jimenez; Norma Vazquez; Lorena Rojas-Vega; Dario R Alessi; Norma A Bobadilla; Gerardo Gamba Journal: J Hypertens Date: 2018-02 Impact factor: 4.844
Authors: Frances-Rose Schumacher; Keith Siew; Jinwei Zhang; Clare Johnson; Nicola Wood; Sarah E Cleary; Raya S Al Maskari; James T Ferryman; Iris Hardege; Nichola L Figg; Radoslav Enchev; Axel Knebel; Kevin M O'Shaughnessy; Thimo Kurz Journal: EMBO Mol Med Date: 2015-10 Impact factor: 12.137